BeiGene (NASDAQ:BGNE) Stock Quotes, Forecast and News Summary

Q: What sector and industry does BeiGene (BGNE) operate in?

BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeiGene Stock (NASDAQ: BGNE) stock price, news, charts, stock research, profile.

Open	$247.00
Close	$246.04
Volume / Avg.	607.53K / 290.14K
Day Range	$243.06 - $248.16
52 Wk Range	126.97 - 238.80
Market Cap	$26.13B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	82
Short Interest	3.86%
Days to Cover	6.5

Recent News

FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients

The FDA's advisory committee is set to evaluate the use of PD-1 inhibitors in gastric cancer patients, focusing on the risks and benefits for those with varying PD-L1 levels, including low expressers.

Vandana Singh

Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug

JMP Securities has initiated coverage on BeiGene highlighting the Chinese biotech company as a 'unique investment opportunity.' The firm's leading drug, Brukinsa (zanubrutinib), is emerging in the competitive BTK inhibitor market.

Vandana Singh

Oxford Industries Reports Weak Results, Joins Viper Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

May

Jul

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$247.00
Close	$246.04
Volume / Avg.	607.53K / 290.14K
Day Range	$243.06 - $248.16
52 Wk Range	126.97 - 238.80
Market Cap	$26.13B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	82
Short Interest	3.86%
Days to Cover	6.5

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BeiGene (BGNE) stock?

You can purchase shares of BeiGene (NASDAQ:BGNE) through any online brokerage.

View our list of the best stock brokerages

Who are BeiGene (BGNE) competitors?

Other companies in BeiGene’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for BeiGene (BGNE) stock?

BeiGene has a consensus price target of $262.46.

What is the current price for BeiGene (BGNE)?

The stock price for BeiGene (NASDAQ: BGNE) is $246.04 last updated October 4, 2024 at 4:00 PM EDT.

Does BeiGene (BGNE) pay a dividend?

There are no upcoming dividends for BeiGene.

When is BeiGene (NASDAQ:BGNE) reporting earnings?

BeiGene’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is BeiGene (BGNE) going to split?

There is no upcoming split for BeiGene.

What sector and industry does BeiGene (BGNE) operate in?

BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge